England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer therapy that can stop cancer progression for nearly three times as long as existing treatments.

One early adopter describes how he was in remission ‘within the first two or three weeks’ after the treatment

It sneaks toxic drugs inside cancer cells to hit them hard while minimising side-effects.